Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone
Completed
Indivior Inc.
Phase 2
2008-03-01
The purpose of this study is to compare the presence, degree, time course and profile of
opioid withdrawal symptoms associated with induction onto new formulations of buprenorphine
or buprenorphine/naloxone in persons with active opioid dependence. The primary outcome
measure is the severity of withdrawal symptoms measured using the Clinical Opiate Withdrawal
Scale (COWS). The primary study hypothesis is that neither drug formulation will precipitate
an opioid withdrawal syndrome.
Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
Terminated
National Institute on Drug Abuse (NIDA)
N/A
2002-09-01
Buprenorphine is a drug that may be helpful in treating opioid dependent individuals who were
previously maintained on methadone. The purpose of this study is to determine the effects of
different doses of buprenorphine/naloxone in treating opioid dependent individuals who were
previously maintained on methadone.
The purpose of this study is to determine target dose range of buprenorphine/naloxone
combination tablet that provides therapeutic response in opiate addicts with low to moderate
dependence, and to identify appropriate initial induction dose in opiate addicts with low to
moderate dependence."
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1
Withdrawn
National Institute on Drug Abuse (NIDA)
Phase 2
1997-04-01
The purpose of this study is to assess the clinical efficacy of the buprenorphine/naloxone
combination tablet for alternate-day dosing and determine whether multiples of the daily dose
are necessary to maintain an effective alternate day dosing regimen.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
